Author

Antonio Gasbarrini

TOWARDS A PERSONALIZED APPROACH IN ULCERATIVE COLITIS: ROLE OF OCTN1 IN PREDICTING DISEASE SEVERITY AND INDIVIDUAL RESPONSE TO THERAPY
TOWARDS A PERSONALIZED APPROACH IN ULCERATIVE COLITIS: ROLE OF OCTN1 IN PREDICTING DISEASE SEVERITY AND INDIVIDUAL RESPONSE TO THERAPY

Antonio Gasbarrini  et al.

ANTIBIOTIC RESISTANCE TRENDS OF HELICOBACTER PYLORI NAÏVE PATIENTS IN THE PERIOD 2013-2020: ANALYSIS OF THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
ANTIBIOTIC RESISTANCE TRENDS OF HELICOBACTER PYLORI NAÏVE PATIENTS IN THE PERIOD 2013-2020: ANALYSIS OF THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Antonio Gasbarrini  et al.

FECAL MICROBIOTA TRANSPLANTATION FOR RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION IN PATIENTS WITH ULCERATIVE COLITIS
FECAL MICROBIOTA TRANSPLANTATION FOR RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION IN PATIENTS WITH ULCERATIVE COLITIS

Antonio Gasbarrini  et al.

EMERGING ROLE OF IL-33/ST2 AND GUT MICROBIOTA AXIS IN PREDICTING MUCOSAL AND HISTOLOGICAL RESPONSE TO ANTI-TNF THERAPY IN ULCERATIVE COLITIS
EMERGING ROLE OF IL-33/ST2 AND GUT MICROBIOTA AXIS IN PREDICTING MUCOSAL AND HISTOLOGICAL RESPONSE TO ANTI-TNF THERAPY IN ULCERATIVE COLITIS

Antonio Gasbarrini  et al.

IMMUNE AND NON IMMUNE CHANGES FOLLOWING FMT IN EXPERIMENTAL COLITIS: EMERGING PATHWAYS OF FMT-DERIVED MUCOSAL HEALING
IMMUNE AND NON IMMUNE CHANGES FOLLOWING FMT IN EXPERIMENTAL COLITIS: EMERGING PATHWAYS OF FMT-DERIVED MUCOSAL HEALING

Antonio Gasbarrini  et al.

ENDOSCOPIC ULTRASOUND DIRECT PORTAL PRESSURE MEASUREMENT IS MORE RELIABLE THAN HEPATIC VENOUS PRESSURE GRADIENT MEASUREMENT IN PATIENTS WITH PRE-SINUSOIDAL FORMS OF PORTAL HYPERTENSION
ENDOSCOPIC ULTRASOUND DIRECT PORTAL PRESSURE MEASUREMENT IS MORE RELIABLE THAN HEPATIC VENOUS PRESSURE GRADIENT MEASUREMENT IN PATIENTS WITH PRE-SINUSOIDAL FORMS OF PORTAL HYPERTENSION

Antonio Gasbarrini  et al.

THE POCER INDEX: APPLICATION OF A NOVEL ENDOSCOPIC SCORE IN A REAL-LIFE COHORT OF PATIENTS WITH CROHN'S DISEASE AFTER SURGERY
THE POCER INDEX: APPLICATION OF A NOVEL ENDOSCOPIC SCORE IN A REAL-LIFE COHORT OF PATIENTS WITH CROHN'S DISEASE AFTER SURGERY

Antonio Gasbarrini  et al.

PREVALENCE OF, AND MICROBIAL RISK FACTORS FOR, IRRITABLE BOWEL SYNDROME AND FUNCTIONAL DYSPEPSIA AFTER ACUTE GASTROINTESTINAL INFECTION: A SYSTEMATIC REVIEW AND META-ANALYSIS
PREVALENCE OF, AND MICROBIAL RISK FACTORS FOR, IRRITABLE BOWEL SYNDROME AND FUNCTIONAL DYSPEPSIA AFTER ACUTE GASTROINTESTINAL INFECTION: A SYSTEMATIC REVIEW AND META-ANALYSIS

Antonio Gasbarrini  et al.

HUMAN EXTRACHROMOSOMAL CIRCULAR DNA IS AN EMERGING BIOMARKER IN INFLAMMATORY BOWEL DISEASE
HUMAN EXTRACHROMOSOMAL CIRCULAR DNA IS AN EMERGING BIOMARKER IN INFLAMMATORY BOWEL DISEASE

Antonio Gasbarrini  et al.

THE SOLUTE CARRIER LC22A4/OCTN1AS A NOVEL IBD DETERMINANT AT THE MICROBE-HOST INTERFACE
THE SOLUTE CARRIER LC22A4/OCTN1AS A NOVEL IBD DETERMINANT AT THE MICROBE-HOST INTERFACE

Antonio Gasbarrini  et al.

IMMUNE AND NON IMMUNE CHANGES FOLLOWING FMT IN EXPERIMENTAL COLITIS: EMERGING PATHWAYS OF FMT-DERIVED MUCOSAL HEALING
IMMUNE AND NON IMMUNE CHANGES FOLLOWING FMT IN EXPERIMENTAL COLITIS: EMERGING PATHWAYS OF FMT-DERIVED MUCOSAL HEALING

Antonio Gasbarrini  et al.

THE SOLUTE TRANSPORTER OCTN1/SLC22A4 AFFECTS DISEASE SEVERITY AND RESPONSE TO INFLIXIMAB IN EXPERIMENTAL COLITIS: ROLE OF GUT MICROBIOTA AND IMMUNE MODULATION
THE SOLUTE TRANSPORTER OCTN1/SLC22A4 AFFECTS DISEASE SEVERITY AND RESPONSE TO INFLIXIMAB IN EXPERIMENTAL COLITIS: ROLE OF GUT MICROBIOTA AND IMMUNE MODULATION

Antonio Gasbarrini  et al.

GENERAL PRACTITIONER DATABASE NAFLD (GPS-NAFLD) STUDY: PREVALENCE OF ADVANCED LIVER FIBROSIS AMONG ITALIAN PRIMARY CARE PATIENTS WITH NAFLD
GENERAL PRACTITIONER DATABASE NAFLD (GPS-NAFLD) STUDY: PREVALENCE OF ADVANCED LIVER FIBROSIS AMONG ITALIAN PRIMARY CARE PATIENTS WITH NAFLD

Antonio Gasbarrini  et al.

EXPERIENCE WITH SINGLE-CAPSULE BISMUTH QUADRUPLE THERAPY IN 6,000 PATIENTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
EXPERIENCE WITH SINGLE-CAPSULE BISMUTH QUADRUPLE THERAPY IN 6,000 PATIENTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Antonio Gasbarrini  et al.

ENDOSCOPIC BALLOON DILATATION ASSOCIATED WITH BIOLOGICAL THERAPY IN CROHN’S DISEASE STRICTURES: A SINGLE CENTER EXPERIENCE
ENDOSCOPIC BALLOON DILATATION ASSOCIATED WITH BIOLOGICAL THERAPY IN CROHN’S DISEASE STRICTURES: A SINGLE CENTER EXPERIENCE

Antonio Gasbarrini  et al.

SPECIFIC GUT MICROBIOTA SIGNATURES ARE ASSOCIATED WITH SYMPTOMATIC LACTOSE MALABSORPTION
SPECIFIC GUT MICROBIOTA SIGNATURES ARE ASSOCIATED WITH SYMPTOMATIC LACTOSE MALABSORPTION

Antonio Gasbarrini  et al.

EFFECTIVENESS AND SAFETY OF SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS VEDOLIZUMAB FORMULATION IN INFLAMMATORY BOWEL DISEASE PATIENTS IN CLINICAL REMISSION
EFFECTIVENESS AND SAFETY OF SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS VEDOLIZUMAB FORMULATION IN INFLAMMATORY BOWEL DISEASE PATIENTS IN CLINICAL REMISSION

Antonio Gasbarrini  et al.

DYNAMIC CONTRAST-ENHANCED ULTRASOUND (D-CEUS) TO PREDICT BIOLOGICAL BEHAVIOR IN PANCREATIC CANCER: MONOCENTRIC STUDY PRELIMINARY RESULTS
DYNAMIC CONTRAST-ENHANCED ULTRASOUND (D-CEUS) TO PREDICT BIOLOGICAL BEHAVIOR IN PANCREATIC CANCER: MONOCENTRIC STUDY PRELIMINARY RESULTS

Antonio Gasbarrini  et al.

VALIDATION OF CACLD RISK MODEL FOR DIAGNOSIS OF COMPENSATED ADVANCED CHRONIC LIVER DISEASE (CACLD) IN NAFLD PATIENTS
VALIDATION OF CACLD RISK MODEL FOR DIAGNOSIS OF COMPENSATED ADVANCED CHRONIC LIVER DISEASE (CACLD) IN NAFLD PATIENTS

Antonio Gasbarrini  et al.

DYNAMICS OF LIVER STIFFNESS PREDICTS HEPATOCELLULAR CARCINOMA AND ASCITES IN PATIENTS WITH HEPATITIS C VIRUS RELATED CIRRHOSIS TREATED WITH DIRECT ACTING ANTIVIRALS
DYNAMICS OF LIVER STIFFNESS PREDICTS HEPATOCELLULAR CARCINOMA AND ASCITES IN PATIENTS WITH HEPATITIS C VIRUS RELATED CIRRHOSIS TREATED WITH DIRECT ACTING ANTIVIRALS

Antonio Gasbarrini  et al.

Item 21 - 40 / 85
1
2
3 4 5